JP2024538595A5 - - Google Patents

Info

Publication number
JP2024538595A5
JP2024538595A5 JP2024519079A JP2024519079A JP2024538595A5 JP 2024538595 A5 JP2024538595 A5 JP 2024538595A5 JP 2024519079 A JP2024519079 A JP 2024519079A JP 2024519079 A JP2024519079 A JP 2024519079A JP 2024538595 A5 JP2024538595 A5 JP 2024538595A5
Authority
JP
Japan
Prior art keywords
peptide
seq
residue
amino acid
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024519079A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538595A (ja
Filing date
Publication date
Priority claimed from GBGB2113858.1A external-priority patent/GB202113858D0/en
Application filed filed Critical
Publication of JP2024538595A publication Critical patent/JP2024538595A/ja
Publication of JP2024538595A5 publication Critical patent/JP2024538595A5/ja
Pending legal-status Critical Current

Links

JP2024519079A 2021-09-28 2022-09-28 セリアック病エピトープ Pending JP2024538595A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2113858.1A GB202113858D0 (en) 2021-09-28 2021-09-28 Peptides
GB2113858.1 2021-09-28
PCT/GB2022/052450 WO2023052759A1 (en) 2021-09-28 2022-09-28 Celiac disease epitopes

Publications (2)

Publication Number Publication Date
JP2024538595A JP2024538595A (ja) 2024-10-23
JP2024538595A5 true JP2024538595A5 (https=) 2025-10-06

Family

ID=78399559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519079A Pending JP2024538595A (ja) 2021-09-28 2022-09-28 セリアック病エピトープ

Country Status (6)

Country Link
US (1) US20240400692A1 (https=)
EP (1) EP4408539A1 (https=)
JP (1) JP2024538595A (https=)
CA (1) CA3233346A1 (https=)
GB (1) GB202113858D0 (https=)
WO (1) WO2023052759A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212885D0 (en) * 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof
ES2402286B1 (es) * 2011-09-29 2014-03-04 Universidad De Valladolid Péptido inmunogénico del gluten y sus aplicaciones.
GB201802338D0 (en) 2018-02-13 2018-03-28 Univ Oslo Antigen binding proteins
JP7420330B2 (ja) * 2019-06-13 2024-01-23 学校法人藤田学園 アレルギーの抗原およびそのエピトープ
JP2023500799A (ja) * 2019-10-18 2023-01-11 トラスティーズ オブ ボストン ユニバーシティ Ｃａｌ－ｔコンストラクトおよびその使用

Similar Documents

Publication Publication Date Title
JP2024063213A5 (https=)
JP2021524270A5 (https=)
JP2019511201A5 (https=)
CN106046155A (zh) 用于治疗hbv感染及相关疾病的多肽及抗体
JP2024507540A5 (https=)
CN116925215A (zh) 抗血清白蛋白纳米抗体及其衍生物
CN102180969B (zh) 抗肝癌活性单克隆抗体及其应用
CN110616192A (zh) 一种抗人神经丝轻链（nefl）的单克隆抗体及其应用
JP7828154B2 (ja) Ｂ型肝炎ウイルス表面抗原のエピトープおよびこれに特異的に結合するｂ型肝炎ウイルス中和結合分子
JP5977346B2 (ja) Ｂ型肝炎ウイルス表面抗原のエピトープおよびその使用
JP2013520487A5 (https=)
Wi et al. Construction and characterization of an anti-hepatitis B virus preS1 humanized antibody that binds to the essential receptor binding site
JP2023544211A (ja) Ｓａｒｓ－ｃｏｖ－２を標的とするポリペプチドならびに関連する組成物および方法
JPH07509609A (ja) ラスタンパク質活性を阻害するペプチド，その製造及び利用
WO2025241210A9 (zh) RSV pre-F突变体及其生产方法和用途
EP4471055A1 (en) Epitope peptide and antibody for treating hbv infection and related diseases
JP2022542294A5 (https=)
JP2024538595A5 (https=)
JP2008517918A5 (https=)
US11053302B2 (en) Stabilized and autonomous antibody VH domain
KR101349413B1 (ko) 비브리오 패혈증균 알티엑스에이원 항원에 결합하는 단일클론항체 제조와 진단 항원을 제공하기 위한 재조합 단백질 발현벡터
JP2002020399A (ja) ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体
Komatsu et al. Four different clones of mouse anti-acetyllysine monoclonal antibodies having different recognition properties share a common immunoglobulin framework structure
EP2552958B1 (en) Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r)
CN1572798A (zh) Sars冠状病毒相关多肽及其应用